China: International Trade & Investment

China has rapidly emerged as a dominant force in early-stage biotech innovation, challenging traditional U.S. hubs like San Francisco and Boston through faster development timelines, lower clinical trial costs, and aggressive government support. As deal volume between Western biopharma companies and Chinese biotechs surges dramatically, industry leaders must navigate the complex balance between accessing China's growing scientific contributions and managing heightened geopolitical tensions and U.S. regulato

China has introduced comprehensive administrative regulations governing outbound investment activities by domestic investors, establishing systematic rules for approval procedures, security reviews, and compliance requirements. The new framework integrates previously scattered regulatory requirements on national security, data protection, and technology export into a unified system, while introducing significant penalties for violations. High-tech enterprises and investors must now navigate enhanced scrutin

2026年6月3日，爱尔兰高等法院在 TikTok Technology Limited v Data Protection Commission [2026] IEHC 347 一案中，就TikTok针对爱尔兰数据保护委员会（DPC）关于数据跨境传输的处罚决定提出的上诉作出实体判决...